Several gene-editing strategies for autosomal dominant ELANE mutations associated with severe congenital neutropenia (CN)1 or cyclic neutropenia (CyN) were reported to be suitable for potential clinical translation.2 The gene discussed is ELANE; the disease is cyclic hematopoiesis.